Koninklijke Philips (NYSE:PHG) Stake Raised by Holderness Investments Co.

Holderness Investments Co. raised its holdings in shares of Koninklijke Philips (NYSE:PHGFree Report) by 3.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,807 shares of the technology company’s stock after acquiring an additional 546 shares during the quarter. Holderness Investments Co.’s holdings in Koninklijke Philips were worth $424,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in PHG. Wealth Enhancement Advisory Services LLC increased its stake in Koninklijke Philips by 6.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 60,365 shares of the technology company’s stock valued at $1,207,000 after buying an additional 3,891 shares during the period. Principal Securities Inc. acquired a new position in shares of Koninklijke Philips in the fourth quarter worth $27,000. Corient Private Wealth LLC raised its holdings in shares of Koninklijke Philips by 21.0% during the fourth quarter. Corient Private Wealth LLC now owns 64,724 shares of the technology company’s stock worth $1,510,000 after acquiring an additional 11,211 shares in the last quarter. Envestnet Portfolio Solutions Inc. boosted its position in Koninklijke Philips by 12.9% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,515 shares of the technology company’s stock valued at $668,000 after purchasing an additional 3,040 shares during the last quarter. Finally, OLD Mission Capital LLC grew its stake in Koninklijke Philips by 434.9% in the fourth quarter. OLD Mission Capital LLC now owns 434,282 shares of the technology company’s stock valued at $10,132,000 after purchasing an additional 353,096 shares in the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.

Koninklijke Philips Stock Performance

Shares of PHG opened at $30.58 on Friday. The firm has a market cap of $28.74 billion, a price-to-earnings ratio of -31.85, a price-to-earnings-growth ratio of 1.06 and a beta of 0.73. The company’s fifty day moving average is $28.88 and its 200-day moving average is $25.74. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60. Koninklijke Philips has a 12 month low of $17.75 and a 12 month high of $31.50.

Koninklijke Philips (NYSE:PHGGet Free Report) last posted its earnings results on Monday, July 29th. The technology company reported $0.32 EPS for the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. The firm had revenue of $4.80 billion for the quarter. Equities analysts expect that Koninklijke Philips will post 1.51 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Get Our Latest Stock Analysis on PHG

Koninklijke Philips Profile

(Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Recommended Stories

Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHGFree Report).

Institutional Ownership by Quarter for Koninklijke Philips (NYSE:PHG)

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.